Hematología y Hemoterapia

Resultados: 408
Tipo Título / Nombre Autor(es) Año
Do Guidelines Influence Diagnostic and Therapeutic Practice in Immune Thrombocytopenia? Results of a Multicenter Retrospective Study Lozano ML, Mingot-Castellano ME, Perera M, Jarque I, Campos RM, González-López TJ, et al 2019
Predictive Factors for Thrombopoietin Receptor Agonist Free Responses in Chronic ITP Patients: A Multicenter Retrospective Study with Long-Term Follow-up Lozano ML, Mingot-Castellano ME, Perera M, Jarque I, Campos RM, González-López TJ, et al 2019
A New Molecular Variant in the PTGS1 Gene That Abrogates Generation of Thromboxane A2 Synthesis and Associates with Platelet Dysfunction and Bleeding Palma Barqueros V, Chan M, Crescente M, Bastida JM, Almarza E, Suarez Varela S, et al 2019
Post-Remission Treatment with Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) in Adult Patients with High-Risk (HR) Philadelphia Chromosome-Negative (Ph-neg) Acute Lymphoblastic Leukemia (ALL) According to Their Minimal Residual Disease (MRD). Final Results of the Pethema ALL-HR-11 Trial Ribera JM, Morgades M, Prob M, Ciudad J, Montesinos P, Barba P, et al 2019
Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus Montesinos P, Bergua J, Infante J, Esteve J, Guimaraes JE, Sierra J, et al 2019
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Álvarez RM, González-López TJ, et al 2019
Evolution of myeloid-derived suppressor cells and objective response rate in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL) patients after receiving immunotherapy Jiménez Cortegana C, Palazón Carrión N, Nogales Fernández E, Nieto García MA, Sánchez Margalet V, Alamo de la Gala MDC, et al 2019
Clinicobiologic characteristics and outcome of elderly frail patients with acute lymphoblastic leukemia included in a specific protocol (all-07FRAIL) Ribera JM, García Calduch O, Gil C, González Campos J, Moreno MJ, Barba P, et al 2019
Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia Megías-Vericat JE, Martínez-Cuadrón D, López JM, Bergua JM, Tormo M, Serrano J, et al 2019
Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature Rodríguez-Otero P, Mateos MV, Martínez-López J, Hernández MT, Ocio EM, Rosiñol L, et al 2019